BE1002710A5 - Preparation au diclofenac sodique a effet prolonge. - Google Patents

Preparation au diclofenac sodique a effet prolonge. Download PDF

Info

Publication number
BE1002710A5
BE1002710A5 BE8900683A BE8900683A BE1002710A5 BE 1002710 A5 BE1002710 A5 BE 1002710A5 BE 8900683 A BE8900683 A BE 8900683A BE 8900683 A BE8900683 A BE 8900683A BE 1002710 A5 BE1002710 A5 BE 1002710A5
Authority
BE
Belgium
Prior art keywords
diclofenac sodium
preparation
long
term effect
component
Prior art date
Application number
BE8900683A
Other languages
English (en)
Original Assignee
Ss Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ss Pharmaceutical Co filed Critical Ss Pharmaceutical Co
Application granted granted Critical
Publication of BE1002710A5 publication Critical patent/BE1002710A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Préparation au diclofénac sodique à effet prolongé, caractérisée en ce qu'elle comprend un composant de diclofénac sodique à libération retardée, ce composant comprenant une composition pharmaceutique munie d'un enrobage retard, cette composition phamaceutique comprenant du diclofénac sodique et un acide organique.
BE8900683A 1988-08-16 1989-06-22 Preparation au diclofenac sodique a effet prolonge. BE1002710A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20349888 1988-08-16

Publications (1)

Publication Number Publication Date
BE1002710A5 true BE1002710A5 (fr) 1991-05-14

Family

ID=16475153

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8900683A BE1002710A5 (fr) 1988-08-16 1989-06-22 Preparation au diclofenac sodique a effet prolonge.

Country Status (13)

Country Link
US (1) US4968505A (fr)
JP (1) JPH07116028B2 (fr)
KR (1) KR950003610B1 (fr)
BE (1) BE1002710A5 (fr)
CA (1) CA1319616C (fr)
CH (1) CH678813A5 (fr)
DE (1) DE3915150C2 (fr)
FR (1) FR2635460B1 (fr)
GB (1) GB2221842B (fr)
HK (1) HK48194A (fr)
IT (1) IT1231517B (fr)
NL (1) NL194882C (fr)
SE (1) SE509029C2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
US5015481A (en) * 1990-05-03 1991-05-14 G. D. Searle & Co. Stabilized pharmaceutical admixture composition
JPH04230625A (ja) * 1990-12-27 1992-08-19 Standard Chem & Pharmaceut Corp Ltd 噴霧乾燥したジクロフェナクナトリウムを含み腸溶性の被覆を有するマイクロカプセルからなる微分散した錠剤組成物の製造方法
EP0520119A1 (fr) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Composition à base de diclofenac pour l'administration orale
US5518737A (en) * 1991-10-16 1996-05-21 Orion-Yhtyma Oy Peroral drug delivery system
WO1994003160A1 (fr) * 1992-08-05 1994-02-17 F.H. Faulding & Co. Limited Composition pharmaceutique sous forme de granules
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
ES2262174T3 (es) * 1996-09-30 2006-11-16 Alza Corporation Forma de dosificacion y procedimiento de administracion de medicamentos.
EP1690531A3 (fr) * 1996-09-30 2010-01-20 Alza Corporation Forme de dosage et méthode d'administration de médicament
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
ES2129010B1 (es) * 1997-01-02 2000-01-16 Gold Oscar Composicion de accion prolongada en granulos que contienen 4-nitro-2- fenoximetansulfonanilida y su procedimiento de preparacion.
ES2129356B1 (es) * 1997-03-26 2000-01-16 Pierre Fabre Iberica S A Forma farmaceutica de liberacion prolongada y procedimiento para su o btencion.
US6312724B1 (en) 1997-04-04 2001-11-06 Isa Odidi Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6699508B1 (en) 1998-08-10 2004-03-02 Asahi Kasei Pharma Corporation Sustained release oral preparations of fasudil hydrochloride
US6989159B2 (en) * 2000-08-10 2006-01-24 Jds Pharmaceuticals, Llc Pharmaceutical compositions containing lithium carbonate
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
BRPI0517166A (pt) * 2004-12-09 2008-09-30 Celgene Corp uso de d-treo-metilfenidato ou um sal do mesmo
WO2012169614A1 (fr) * 2011-06-10 2012-12-13 ニプロ株式会社 Procédé de production de comprimés orodispersibles
US8962020B2 (en) * 2012-07-26 2015-02-24 Glycadia Inc. Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
WO2017084680A1 (fr) * 2015-11-17 2017-05-26 Rontis Hellas S.A. Composition pharmaceutique contenant un médicament anti-inflammatoire non stéroïdien et un inhibiteur de pompe à protons
CN114306260B (zh) * 2021-12-29 2023-10-24 濮阳市汇元药业有限公司 一种新型双氯芬酸钠片及其制备方法
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2039737A (en) * 1978-12-22 1980-08-20 Panoz D Galenical forms for administration of medicaments by oral by oral route with programmed release and processes for preparing same
WO1981001652A1 (fr) * 1979-12-07 1981-06-25 D Panoz Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenues
EP0156077A1 (fr) * 1983-12-21 1985-10-02 ELAN CORPORATION, Plc Formulation pharmaceutique à absorption contrôlée
EP0209975A1 (fr) * 1985-06-04 1987-01-28 Nitto Denko Corporation Préparation adhésive analgésique anti-inflammatoire
EP0218148A1 (fr) * 1985-09-26 1987-04-15 Chugai Seiyaku Kabushiki Kaisha Composition pharmaceutique à libération lente
EP0232155A2 (fr) * 1986-02-03 1987-08-12 Elan Corporation Plc Système pour la libération de médicaments
GB2217598A (en) * 1988-03-25 1989-11-01 Ciba Geigy Effervescent tablet containing diclofenac

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655507B (fr) * 1983-01-12 1986-04-30
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
US4814183A (en) * 1987-08-31 1989-03-21 Merck & Co., Inc. Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2039737A (en) * 1978-12-22 1980-08-20 Panoz D Galenical forms for administration of medicaments by oral by oral route with programmed release and processes for preparing same
WO1981001652A1 (fr) * 1979-12-07 1981-06-25 D Panoz Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenues
EP0156077A1 (fr) * 1983-12-21 1985-10-02 ELAN CORPORATION, Plc Formulation pharmaceutique à absorption contrôlée
EP0209975A1 (fr) * 1985-06-04 1987-01-28 Nitto Denko Corporation Préparation adhésive analgésique anti-inflammatoire
EP0218148A1 (fr) * 1985-09-26 1987-04-15 Chugai Seiyaku Kabushiki Kaisha Composition pharmaceutique à libération lente
EP0232155A2 (fr) * 1986-02-03 1987-08-12 Elan Corporation Plc Système pour la libération de médicaments
GB2217598A (en) * 1988-03-25 1989-11-01 Ciba Geigy Effervescent tablet containing diclofenac

Also Published As

Publication number Publication date
JPH07116028B2 (ja) 1995-12-13
NL194882B (nl) 2003-02-03
SE8901593D0 (sv) 1989-05-03
SE8901593L (sv) 1990-12-06
NL8901200A (nl) 1990-03-16
CA1319616C (fr) 1993-06-29
HK48194A (en) 1994-05-27
JPH02237918A (ja) 1990-09-20
GB8910271D0 (en) 1989-06-21
DE3915150A1 (de) 1990-03-01
DE3915150C2 (de) 1997-04-17
GB2221842B (en) 1991-10-16
IT1231517B (it) 1991-12-07
FR2635460A1 (fr) 1990-02-23
NL194882C (nl) 2003-06-04
GB2221842A (en) 1990-02-21
KR900002769A (ko) 1990-03-23
CH678813A5 (fr) 1991-11-15
IT8948030A0 (it) 1989-06-01
US4968505A (en) 1990-11-06
FR2635460B1 (fr) 1994-09-16
SE509029C2 (sv) 1998-11-30
KR950003610B1 (ko) 1995-04-17

Similar Documents

Publication Publication Date Title
BE1002710A5 (fr) Preparation au diclofenac sodique a effet prolonge.
YU46701B (sh) Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance
BR9813474A (pt) Processo para intensificar uma absorção pelo animal de pelo menos um composto lipofìlico, e, composição
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
GR1002097B (en) A process for providing a composition an analgesic in combination with a h1 or h2 receptor blocker proto n pump ihibitor or combination thereof
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
FR2655266B1 (fr) Compositions pharmaceutiques a base de cimetidine.
ATE128863T1 (de) Arzneimittelformulierungen mit verzögerter wirkstoffabgabe.
IT1255449B (it) Uso di nor- e omo-derivati di acidi biliari come promotori di assorbimento di farmaci.
IT8920170A0 (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT8219908A0 (it) Derivati di ferro biodisponibile esenti da gastrolesivita',procedimento di preparazione e relative composizioni farmaceutiche.
BR0011928A (pt) Composto, composição farmacêutica, uso de, um composto e métodos para o tratamento de complicações diabéticas, para o tratamento ou a prevenção do desenvolvimento de condições de doença associadas com velocidade de condução neuronial prejudicada e de neuropatia diabética
IT8920169A0 (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
BR9100297A (pt) Derivados da pirazolina substituidos,processo para sua preparacao,composicao praguicida,processo para combater pragas e para a preparacao de composicoes
FR2515653B1 (fr) Procede de preparation d'esters d'acides hydroxyimino apovincaminiques, esters ainsi obtenus, et compositions pharmaceutiques preparees avec ces esters
OA09439A (fr) "Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent".
MA26522A1 (fr) Composition pharmaceutique pour le traitement du diabete sucre et d'etats associes.
IT8219409A0 (it) Derivati, tiolici dell'eritromicina ad attivita' terapeutica, relativo procedimento di preparazione e composizioni farmaceutiche che licontengono.
DE69208171D1 (de) Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
BR9002201A (pt) Derivados de amidas de ciclopropanoilaminoacidos,processo para sua preparacao,composicao praguicida,processos para combater pragas e para a preparacao de composicoes e derivados de ciclopropanoilaminoacidos
IT8920996A0 (it) Derivati di 2 ammino 1,2,3,4 tetraidronaftalene ad attivita' cardiovascolare, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IE831597L (en) Synergistic antihypertensive pharmaceutical composition.
IT1206309B (it) Derivato dell'indoprofene, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
IT8025345A0 (it) Derivato dell'arginina, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20030630